| UniProt ID | CLN6_HUMAN | |
|---|---|---|
| UniProt AC | Q9NWW5 | |
| Protein Name | Ceroid-lipofuscinosis neuronal protein 6 | |
| Gene Name | CLN6 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 311 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Endoplasmic reticulum . |
|
| Protein Description | ||
| Protein Sequence | MEATRRRQHLGATGGPGAQLGASFLQARHGSVSADEAARTAPFHLDLWFYFTLQNWVLDFGRPIAMLVFPLEWFPLNKPSVGDYFHMAYNVITPFLLLKLIERSPRTLPRSITYVSIIIFIMGASIHLVGDSVNHRLLFSGYQHHLSVRENPIIKNLKPETLIDSFELLYYYDEYLGHCMWYIPFFLILFMYFSGCFTASKAESLIPGPALLLVAPSGLYYWYLVTEGQIFILFIFTFFAMLALVLHQKRKRLFLDSNGLFLFSSFALTLLLVALWVAWLWNDPVLRKKYPGVIYVPEPWAFYTLHVSSRH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 | Phosphorylation | ----MEATRRRQHLG ----CCCHHHHHHCC | 16.05 | 26074081 | |
| 13 | Phosphorylation | RRQHLGATGGPGAQL HHHHCCCCCCCCHHH | 40.65 | 26074081 | |
| 23 | Phosphorylation | PGAQLGASFLQARHG CCHHHHHHHHHHHCC | 25.37 | 23401153 | |
| 31 | Phosphorylation | FLQARHGSVSADEAA HHHHHCCCCCHHHHH | 13.53 | 29255136 | |
| 33 | Phosphorylation | QARHGSVSADEAART HHHCCCCCHHHHHHH | 31.53 | 23927012 | |
| 63 (in isoform 2) | Phosphorylation | - | 21.04 | 22496350 | |
| 104 | Phosphorylation | LLKLIERSPRTLPRS HHHHHHHCCCCCCCC | 13.12 | 24719451 | |
| 140 | Phosphorylation | VNHRLLFSGYQHHLS CCHHHHHCCCCCCCC | 36.24 | 23312004 | |
| 142 | Phosphorylation | HRLLFSGYQHHLSVR HHHHHCCCCCCCCCC | 11.95 | 23312004 | |
| 147 | Phosphorylation | SGYQHHLSVRENPII CCCCCCCCCCCCCHH | 18.12 | 23312004 | |
| 290 | Phosphorylation | DPVLRKKYPGVIYVP CHHHHHHCCCEEEEC | 14.30 | 26552605 | |
| 295 | Phosphorylation | KKYPGVIYVPEPWAF HHCCCEEEECCCCEE | 13.93 | 26552605 | |
| 303 | Phosphorylation | VPEPWAFYTLHVSSR ECCCCEEEEEECCCC | 10.72 | 26552605 | |
| 304 | Phosphorylation | PEPWAFYTLHVSSRH CCCCEEEEEECCCCC | 12.16 | 26552605 | |
| 308 | Phosphorylation | AFYTLHVSSRH---- EEEEEECCCCC---- | 15.77 | 26552605 | |
| 309 | Phosphorylation | FYTLHVSSRH----- EEEEECCCCC----- | 33.03 | 26552605 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CLN6_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CLN6_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CLN6_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TERA_HUMAN | VCP | physical | 18811591 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00149 | Neuronal ceroid lipofuscinosis, including: Infantile Neuronal Ceroid Lipofuscinosis (INCL)/ Santavuo | |||||
| H00810 | Progressive myoclonic epilepsy (PME), including: Lafora disease (LBD); Unverricht-Lundborg disease ( | |||||
| OMIM Disease | ||||||
| 601780 | Ceroid lipofuscinosis, neuronal, 6 (CLN6) | |||||
| 204300 | Ceroid lipofuscinosis, neuronal, 4A (CLN4A) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND MASSSPECTROMETRY. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND MASSSPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND MASSSPECTROMETRY. | |